Uncovering important mechanisms underlying immunotherapy via big data analysis
A series of pan-cancer analyses to provide clinical insights into cancer therapy
Comprehensive understanding of the molecular mechanisms of novel transcriptomic elements in cancer
Widely used data resources for the broad biomedical community
Recent advances in genomic characterization technologies and the explosive genomic information related to disease have accelerated the convergence of discovery science with clinical medicine. Successful translations of genomics into therapeutics and diagnostics reinforce its potential for precision medicine. Analyses of multi-dimensional data provide unique opportunities to understand biological processes and signaling pathways. We aim to utilize cutting-edge techniques in computational biology, RNA biology, and systems biology to identify novel prognostic and diagnostic biomarkers and to develop innovative therapeutic strategies. Our lab utilizes cutting-edge techniques in systems biology to understand the molecular mechanisms of complex diseases
We have been invited to contribute review, commentary and spotlight by multiple journals, including Nature Reviews Clinical Oncology, Nature Biotechnology, Nature Metabolism, Trends in Genetics, Trends in Cancer, Trends in Molecular Medicine, Genome Medicine, and Oncogene. To date, we have published >170 peer-reviewed papers, with a total of > 23,000 citations (Google scholar, H-index = 64). Top impact factor journals include: Nature, Nature Reviews Clinical Oncology, Nature Immunology, Nature Metabolism, Nature Genetics, Nature Biotechnology, Nature Cell Biology, Nature Communications, Cell, Cancer Cell, Cell Stem Cell, Molecular Cell, Cell Systems, Cell Reports, Science, Science Translational Medicine, Nucleic Acids Research, Journal of Clinical Investigation, JNCI, Genome Biology, Genome Medicine, Genome Research. Our long-term goal is to revolutionize the precision medicine to achieve better treatment efficacy that will reduce patient morbidity and mortality.